Dr. Ivan R. Batlle, MD

Dr. Batlle practices at Retina Associates in Lenexa, Kansas.

Dr. Batlle's NPI, 1073510962, was assigned on July 7, 2005. Dr. Batlle graduated from Tulane School of Medicine in 1985. Dr. Batlle holds Kansas license 04-31680.

Dr. Batlle's primary practice is Retina Associates, at 8600 Quivira Rd, Lenexa, KS 66215 in Johnson County. The practice phone is (913) 831-7400.

Dr. Batlle's primary practice is Retina Associates in Lenexa, Kansas. Dmand AI also links Dr. Batlle to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Batlle practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Batlle's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Batlle is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Batlle's licenses on file in 6 states: Kansas, Louisiana, Missouri, Mississippi, Texas and Florida.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, eyelid inflammation, glaucoma, hypertensive retinopathy, inflammation of iris and laser destruction of retinal or choroid lesions among the conditions Dr. Batlle treats.

CMS data shows 20,332 Medicare services from Dr. Batlle across 22 procedure codes in 2024, for 1,207 Medicare patients. Medicare paid $2,255,306 for them. Every service was in an office.

CMS counts 1,207 Medicare patients who saw Dr. Batlle in 2024. The largest group is 75 to 84, with 466 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Batlle's median patient age at 74, with 58% women.

In 2024, Dr. Batlle wrote 346 Medicare Part D claims for 111 patients. 53% of them were for generic drugs. CMS names the drug for 290 of them, across 6 drugs with 11 or more claims each, at $4,341 in total drug cost. In 2023, CMS named 435 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Batlle for performance year 2024, reported as part of a group. Dr. Batlle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Batlle, published from 2015 to 2024. Dr. Batlle's most frequent co-authors are Caroline Robyn Baumal, MD, Dean Eliott, MD and Robert E. Engstrom, MD.

CMS Open Payments shows 174 general payments to Dr. Batlle from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. Dutch Ophthalmic, USA paid the most, $2,500.

Dmand AI lists 2 awards for Dr. Batlle, most recently CMS Stage 1 EHR in 2013.

Dr. Batlle graduated from Tulane School of Medicine in 1985. Dr. Batlle is a member of AAO.

Dr. Batlle is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.